ATP5PB
ATP synthase peripheral stalk subunit b, mitochondrial
Also known as: AT5F1_HUMAN, ATP5F1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24539
- Gene
- ATP5PB
- Ensembl
- ENSG00000116459
- Chromosome
- 1
- Canonical length
- 256 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene encodes the b subunit of the proton channel. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
256 residues, UniProt reviewed canonical sequence.
>P24539|ATP5PB
1 MLSRVVLSAA ATAAPSLKNA AFLGPGVLQA TRTFHTGQPH LVPVPPLPEY GGKVRYGLIP
61 EEFFQFLYPK TGVTGPYVLG TGLILYALSK EIYVISAETF TALSVLGVMV YGIKKYGPFV
121 ADFADKLNEQ KLAQLEEAKQ ASIQHIQNAI DTEKSQQALV QKRHYLFDVQ RNNIAMALEV
181 TYRERLYRVY KEVKNRLDYH ISVQNMMRRK EQEHMINWVE KHVVQSISTQ QEKETIAKCI
241 ADLKLLAKKA QAQPVMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5PB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 128 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 128 nTPM
- tongue: 123 nTPM
- heart muscle: 102 nTPM
- choroid plexus: 52 nTPM
- colon: 48 nTPM
- kidney: 38 nTPM
Single-cell type
- parietal cells: 900 nCPM
- esophageal suprabasal cells: 586 nCPM
- late primary spermatocytes: 584 nCPM
- esophageal apical cells: 517 nCPM
- esophageal basal cells: 487 nCPM
- extravillous trophoblasts: 449 nCPM
Immune cell
- total PBMC: 46 nTPM
- naive CD4 T-cell: 17 nTPM
- myeloid DC: 17 nTPM
- classical monocyte: 16 nTPM
- naive B-cell: 15 nTPM
- T-reg: 15 nTPM
Brain region
- cerebral cortex: 56 nTPM
- pons: 47 nTPM
- cerebellum: 46 nTPM
- white matter: 44 nTPM
- medulla oblongata: 44 nTPM
- thalamus: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5PB.
Disease | ImmuneIEDB
Conditions an epitope on ATP5PB was assayed in.
- sarcoidosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.65
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- proton motive force-driven ATP synthesis
- proton motive force-driven mitochondrial ATP synthesis
- substantia nigra development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP synthase, F0 complex, subunit B/MI25
- ATP synthase, F0 complex, subunit B
- Mitochondrial ATP synthase B chain precursor (ATP-synt_B)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5PB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5PB as an antibody target. Whether an autoantibody or antibody against ATP5PB could matter depends on whether native ATP5PB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5PB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5PB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...